drugset / Trial / NCT03997318
Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a confirmatory/bridging study to evaluate the efficacy and safety of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR) compared with placebo in the treatment of stress urinary incontinence (SUI) in adult Japanese female subjects. Half of the participants will receive AMDC-USR (injections with cells) and the other half will receive placebo.
Timeline
- Start
- 2025-06
- Primary completion
- 2026-06
- Completion
- 2027-06
Outcome
Outcome not reported
Stopped (Enrollment): “Study not initiated due to business decision, no participants enrolled.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Iltamiocel | Cell therapy | — | Other |